Latest / San Antonio News Today | 2 Min News | The Daily News Now!
mRNA Cancer Vaccine Breakthrough | San Antonio News
Merck and Moderna just unveiled groundbreaking Phase 3 results for a personalized mRNA cancer vaccine that’s showing real promise in preventing melanoma recurrence—when paired with Keytruda, it’s like teaching your immune system to hunt down your unique tumor. Built on the same tech that raced us COVID vaccines, this precision therapy could soon tackle bladder, lung, and even osteosarcoma cancers. While scaling up production and affordability remain hurdles, experts envision hospital-based “distributed manufacturing” within five years—and regulatory approval may come as soon as next year…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.